Quanterix Co. (NASDAQ:QTRX) Shares Sold by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP lessened its position in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) by 80.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,840 shares of the company's stock after selling 92,834 shares during the quarter. ExodusPoint Capital Management LP owned about 0.06% of Quanterix worth $243,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Quanterix by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 2,217,225 shares of the company's stock worth $23,569,000 after purchasing an additional 19,386 shares in the last quarter. William Blair Investment Management LLC purchased a new position in Quanterix during the 4th quarter worth $11,290,000. Easterly Investment Partners LLC increased its position in Quanterix by 9.0% during the 4th quarter. Easterly Investment Partners LLC now owns 954,995 shares of the company's stock valued at $10,152,000 after buying an additional 78,862 shares in the last quarter. Geode Capital Management LLC raised its stake in Quanterix by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 863,503 shares of the company's stock valued at $9,181,000 after buying an additional 4,836 shares during the last quarter. Finally, State Street Corp raised its stake in Quanterix by 2.2% in the third quarter. State Street Corp now owns 836,443 shares of the company's stock valued at $10,840,000 after buying an additional 18,050 shares during the last quarter. Hedge funds and other institutional investors own 86.48% of the company's stock.

Quanterix Stock Down 0.2 %

Shares of NASDAQ:QTRX traded down $0.01 during trading on Friday, hitting $5.15. The stock had a trading volume of 804,495 shares, compared to its average volume of 541,094. Quanterix Co. has a 12-month low of $4.67 and a 12-month high of $19.18. The stock has a market capitalization of $199.76 million, a price-to-earnings ratio of -4.86 and a beta of 1.35. The stock has a 50-day simple moving average of $6.86 and a two-hundred day simple moving average of $9.82.

Quanterix (NASDAQ:QTRX - Get Free Report) last posted its quarterly earnings results on Monday, March 17th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.03). The business had revenue of $35.16 million for the quarter, compared to analysts' expectations of $34.93 million. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. As a group, sell-side analysts forecast that Quanterix Co. will post -0.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on QTRX shares. Scotiabank restated an "outperform" rating on shares of Quanterix in a report on Tuesday, March 25th. Canaccord Genuity Group cut their price target on shares of Quanterix from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.